Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review
Journal of Neuroimaging · 2025-01 · 35 (1)
DOI: 10.1111/jon.13251 ↗At a glance
Systematische Übersicht in Journal of Neuroimaging, published online on 2024-12-09. Written by Francesca M Cozzi and 3 co-authors. Institution: Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Camb…. Major MEDLINE topics: Glioblastoma, Diffusion Tensor Imaging, Brain Neoplasms, Disease Progression. Cited 12 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY 4.0). Funded by: Amma Kyei-Mensah Medical Scholarship, Stamps Scholarship, Cancer Research UK Clinical Research Training Fellowship.
Abstract (original language)
Background and purpose Despite multimodal treatment of glioblastoma (GBM), recurrence beyond the initial tumor volume is inevitable. Moreover, conventional MRI has shortcomings that hinder the early detection of occult white matter tract infiltration by tumor, but diffusion tensor imaging (DTI) is a sensitive probe for assessing microstructural changes, facilitating the identification of progression before standard imaging. This sensitivity makes DTI a valuable tool for predicting recurrence. A systematic review was therefore conducted to investigate how DTI, in comparison to conventional MRI, can be used for predicting GBM progression.
Methods
We queried three databases (PubMed, Web of Science, and Scopus) using the search terms: (diffusion tensor imaging OR DTI) AND (glioblastoma OR GBM) AND (recurrence OR progression). For included studies, data pertaining to the study type, number of GBM recurrence patients, treatment type(s), and DTI‐related metrics of recurrence were extracted.
Results
In all, 16 studies were included, from which there were 394 patients in total. Six studies reported decreased fractional anisotropy in recurrence regions, and 2 studies described the utility of connectomics/tractography for predicting tumor migratory pathways to a site of recurrence. Three studies reported evidence of tumor progression using DTI before recurrence was visible on conventional imaging.
Conclusions
These findings suggest that DTI metrics may be useful for guiding surgical and radiotherapy planning for GBM patients, and for informing long‐term surveillance. Understanding the current state of the literature pertaining to these metrics’ trends is crucial, particularly as DTI is increasingly used as a treatment‐guiding imaging modality.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
ORCID profiles: Francesca M Cozzi
Funding
- Amma Kyei-Mensah Medical Scholarship
- Stamps Scholarship
- Cancer Research UK Clinical Research Training Fellowship
- CRUK Cambridge Centre
- National Institute for Health and Care Research
- Career Development Fellowship
- NIHR HealthTech Research Centre in Brain Injury
- NIHR Cambridge Biomedical Research Centre
Cite
APA
Cozzi, F. M., Mayrand, R. C., Wan, Y., & Price, S. J. (2025). Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review. Journal of Neuroimaging, 35(1). https://doi.org/10.1111/jon.13251
Vancouver
Cozzi FM, Mayrand RC, Wan Y, Price SJ. Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review. Journal of Neuroimaging. 2025;35(1). doi:10.1111/jon.13251
BibTeX
@article{Cozzi2025,
author = {Cozzi, Francesca M and Mayrand, Roxanne C and Wan, Yizhou and Price, Stephen J},
title = {Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review},
journal = {Journal of Neuroimaging},
year = {2025},
volume = {35},
number = {1},
doi = {10.1111/jon.13251}
}
EUVIMED